Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Malaria Vaccine and Drug Development Center (MVDC) is a prominent research organization based in Cali, Colombia, dedicated to the development of effective interventions against malaria. The center focuses on the design and clinical testing of malaria vaccine candidates, particularly targeting Plasmodium vivax and Plasmodium falciparum. MVDC operates in close collaboration with the Caucaseco Scientific Research Center and international partners like the NIH and WHO. Their work spans from basic immunology and parasite biology to Phase 1 and Phase 2 clinical trials. Additionally, the center contributes to the development of diagnostic tools and the evaluation of antimalarial drug efficacy in endemic regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Malaria Vaccine and Drug Development Center.